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In the first paper of this series (1), we have described a new and more sensitive 
method allowing  the  detection  of plaques  of hemolysis formed in  thin  mono- 
layer cultures by mouse peritoneal cells (PC). 1 Evidence was presented which 
showed that the plaques were caused by the secretion of a product from a living 
cell,  and that lysis was dependent  on complement. In this paper, we consider 
in greater depth the question of whether the hemolytic product responsible for 
plaque appearance is  antibody.  We also discuss  the  role of cell interaction  in 
its causation and the effects of various metabolic inhibitors on the phenomenon. 
Materials  and Methods 
These were essentially the same as those described in the first paper (1). 
Thoracic Duct Cannulation.--This  was according to the method of Boak and Woodruff (2), 
as modified by Miller and Mitchell (3). 
Antimouse Immunoglobulin Sera.--These were kindly provided by Dr. H. Bazin. They were 
obtained by immunization of rabbits with IgM or IgG fractions of mouse serum. They were 
repeatedly absorbed with  either IgG-  or  IgM-containing preparations  to  obtain  sera  ap- 
parently monospecific for the class of immunoglobulins which was used as the immunizing 
agent.  We checked this monospecificity extensively, using immunoelectrophoretic analysis 
and tanned cell hemagglufination. In the latter test, the anti-IgM sera, which will be most 
critical  to  our argument, had titers of < 1:10 with erythrocytes sensitized with mouse IgG, 
while the anti-IgG sera had titers of 1:652,000  with the same erythrocytes. The reverse situa- 
tion pertained,  though anti-IgM  titers were lower;  thus  the sera were effectively able  to 
discriminate between 19S and 7S classes.  No attempt was made to prepare sera able to dis- 
criminate between the different mouse gamma globulin subclasses.  Further evidence for the 
discriminatory capacity of the sera is given under Results. 
RESULTS 
Behavior In Vitro of Lymphoid Cells from Different  Sources.--It has already 
been shown  by one  of us  (4)  that  mouse lymph node  cells  and  spleen  cells  , 
* Present address: The Walter and Eliza Hall Institute of Medical Research, Parkville 3050, 
Victoria, Australia. 
1  Abbreviations used in this paper: CMC,  carboxymethylcellulose; PC,  mouse peritoneal 
cells;  PFC, plaque-forming cells. 
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placed in the original system described by Ingraham and Bussard (5)  (carboxy- 
methylcellulose [CMC]  medium sealed  between  slide  and  coverslip--"closed 
system") were unable to develop hemolytic plaques during incubation periods 
of up to 72 hr, in contradistinction to the behavior of PC. The new technique 
(ultrathin layers under paraffin oil--"open system"), described in the previous 
article  (1),  was  used to assay again the plaque-forming  capacity of different 
lymphoid cells,  since this technique is about twice as sensitive for the detection 
of plaque-forming cells than the closed technique. 
TABLE  I 
Plaque-Forming Capacity of Lymphoid  Cells from  Nonimmunized  Mice.  Young  Male Mice, 
Open System 
Organ  Concentration of cells  No. of plaques/lO  6 cells 
Spleen  5  X  106  18 
Mesenteric: Exp. 1  20  X  106  0 
"  10  X  106  20 
"  5 X  106  0 
Lymph Node: Exp. 2  5 X  106  8 
Thymus: Exp. 1  5  X  106  10 
Exp. 2  5  X  106  0 
Bone marrow: Exp. 1  5  X  106  0 
Exp. 2  5  X  106  16 
Thoracic duct lymphocytes  3  X  106  0 
Peyer's patch  20  X  106  7 
15  X  106  21 
10  X  106  0 
5  X  106  0 
It can be seen in Table I  that most lymphoid cells showed little or no plaque 
forming capacity in the open CMC microcultures after 24 hr of incubation. It 
must be pointed out that an activity of 20 PFC/106 cells detected with the open 
technique represents an activity of circa 4-5 PFC/108 with the standard  Jerne 
method. This is significantly higher than the usual background found after 1 
hr incubation in agar, and it is thus possible that a slight stimulation in vitro 
was achieved in some experiments, but the minimal plaque numbers stand in 
marked contrast to the results with PC. 
Cell to Cell Interactions.--In  many in vivo (6)  and in vitro (7)  immune re- 
sponses, cell to cell interactions appear to be of importance. We thus wondered 
whether the stimulation of plaque-forming activity in PC required the trigger- BUSSARD~ NOSSAL~ MAZI]~, AND  LEWIS  919 
ing of only one individual cell, or if cooperation between two or more cells were 
required.  Such  interaction  could  be  of  two  types:  interaction  between  two 
essentially different cells (macrophage-lymphocyte or thymus-bone  marrow) 
or between two or more cells of the same class. We have approached the first 
type of interaction by reconstruction experiments and fracfionation procedures, 
and the second by variations in concentration of the population of PC  in the 
incubation system. 
TABLE II 
Plaque-Forming Capacity of a Mixture of Peritoneal Cells and of Lymphoid  Cells from Various 
Sources. Young Male Mice, Open System 
Source of cells  Concentration of cells  Number  of plaques normalized  to  expected peritoneal  cell performance 
Peritoneal cells plus 
Spleen 
Peritoneal cells plus 
Thymus 
Peritoneal cells plus 
Bone marrow 
Peritoneal cells plus 
Mesenteric node 
Peritoneal cells plus 
Thoracic duct cells 
Peritoneal cells plus 
Payer's patch cells 
Thymus cells plus 
Bone marrow cells 
Mesenteric node cells plus 
Bone marrow cells 
% 
5 X  106  80 
5 X  106 
5 X  106  51 
5 X  106 
5 X  106  51 
5 X  106 
5 X  106  80 
5 X  10  6 
3 X  l0  s  52 
3 X  106 
5 X  106  35 
5 X  10  s 
Number of plaques/10  a  cells 
5 X  10  °  0 
5 X  106 
5  X  106  0 
5 X  106 
Reconstruction  Experiments.--Mixtures  of PC  and  of lymphoid  cells from 
different sources have been made and these mixtures submitted to incubation 
in  CMC  following the standard procedure.  The  results of these experiments 
are shown in Table II. It can be concluded that no increased plaque-forming 
activity could be induced in the PC population by addition of spleen, thymus, 
bone marrow, mesenteric nodes, or thoracic duct cells. On the contrary, a slight 
inhibition of the normal expected activity of the PC  alone is observed. This 
effect was investigated by mixing a  constant proportion of PC (5  X  l0  s cells/ 
ml) with an increasing proportion of spleen cells which are not, by themselves, 
plaque-forming. It can be seen, in Table III, that an increase in the proportion 
of spleen cells in the total cell population results in a  marked reduction of the 
relative plaque-forming activity ascribed to the PC.  Since the total cell con- 920  INHIBITION  OF  PERITONEAL  CELL  PLAQUES 
centration was not kept constant, it was not possible to distinguish between a 
specific inhibition of the PC activity by the spleen cells or a nonspecific reduc- 
tion  resulting from the excess of total cell concentration, such  a  nonspecific 
effect being due to an insufficient supply of gases or of metabolites for the cells. 
These experiments show that the various lymphoid organs studied are not 
sources of cells which can readily be shown to interact with PC with resultant 
plaque formation. They do not approach the question of whether heterogeneous 
elements within the PC population may interact. This is best studied by frac- 
tionation of the PC population. One of us has shown in a previous study (8) 
that the removal of the large majority of the macrophage-like population (cells 
attaching to glass) from the peritoneal suspension does not reduce, and some- 
times increases, the plaque-forming activity of the remaining population. It can 
be concluded that  a  large majority of the  "macrophage-like" cells,  plays no 
role in the process of stimulation of plaque formation taking place in vitro. 
TABLE  III 
Effect  of Increased  Concentration of Non-Plaque-Forming  Cells (Spleen  Cells) on Plaque 
Formation by Peritoneal Cells. Young Male Mice,  Open System 
Concentration of peritoneal cells  Concentration of spleen cells  PFC peritoneal cells :t= sE 
lO~/ml  106/ml 
5  0  3100  ±  550 
5  5  2150  4-  193 
5  10  93O  ±  170 
5  15  585  ±  117 
This is not to say that a few macrophages are not still required in the process 
of stimulation, since our fractionation procedures have, by no means, removed 
100% of the macrophages from the initial cell population. 
E3fect of Concentration  of CeUs.--If  cell to cell interaction between two  (or 
more) cells of the initial population is required for the phenomenon of plaque 
formation to take place, the plaque number ought to be dependent on the con- 
centration of the  cells  in  the  incubation system.  Experiments  using  concen- 
trations of PC of from 0.12 X  106 to 10 X  106/ml have been performed using 
both the open and the closed CMC systems, and both young male and retired 
breeder mice. Some representative results are presented in Tables IV and V. 
As expected, plaque-forming activity (PFC/106 cells)  of a population of spleen 
cells from immunized mice was  relatively independent  of cell  concentration 
over the whole range studied, though some variation, not  statistically signifi- 
cant, was encountered, especially with the open technique. This is not the case 
for peritoneal cells from unimmunized young mice.  Three  groups differ sig- 
nificantly in their plaque-forming activity (P <  0.05). At low concentrations 
(0.6-1  million  cells/ml)  a  small  or  medium  activity  is  observed  (9-32 %  of BUSSARD,  NOSSAL,  MAZIE,  AND  LEWIS  921 
PFC/10  ~) ; for medium concentrations (2.5-10 million cells/ml) maximal activi- 
ties  are  recorded;  at  high  concentration  (10  million  cells/ml)  the  activity  is 
significantly  decreased.  With  retired  breeder  female  mice,  somewhat  similar 
results have been recorded,  though individual variability between  day to day 
experiments was more marked (Table V). In addition it should be pointed out 
that,  for very low concentrations  (0.1  X  108  cells/ml  and  below)  individual 
TABLE IV 
Effect of Concentration of Cells on the Rdative Plaque-Forming Activity (PFC/IO  6) of 
Immune Spleen Cells or of Nonimmune Peritoneal Cells. 
Young Male Mice, Open Systems 
Percentage of maximum 4-  sE 
Concentration  of cells (lO~/ml)  Spleen cells from immunized mice  Peritoneal cells from unimmunized mice 
Closed technique  Open technique  Closed technique  Open technique 
10  87  4-  2.5  73  4- 4.5  67  4-  5  52  4-  6 
5  95  4- 4  70  4-  6  79  4-  9.5  100  4-  12 
2.5  100  4-  9.5  88  4-  7  100  4-  15  19  4-  7 
1.25  86  4-  8  100  4-  8  32  4-  8  9  4-  3.5 
0.61  88  4-  8  82  4-  6  24  4- 4.5  -- 
TABLE  V 
Effect  of Concentration of Cells on the Relative Plaque-Forming  Activity  (PFC/  IO  6) 
of Nonlmmune Peritoneal  Cells. Retired  Breeder Mice,  Open  System 
PFC/I0 6 4- SE 
Concentration of ceils 
Exp. 1  Exp. 2 
106/ml 
2  --  28,100  4- 910 
1  58,700  4-  10,800  40,200  4- 4,150 
0.5  43,000  4-  5,100  53,000  4- 4,900 
0.25  47,300  4-  7,700  53,600  4-  8,500 
0.12  28,000  4-  7,700  1,530  4-  840 
variations  from preparation  to preparation  from the  same  initial  suspension, 
were so high that these results could scarcely have been considered as falling 
within a normal distribution. Nevertheless, in Experiment 2, recorded in Table 
V,  and in five other experiments  of similar design,  a  striking  and abrupt fall- 
off in expected plaque-forming ability occurred at  a  certain threshold in con- 
centration.  For example,  in Experiment  2,  the  individual  microcultures with 
the lowest cell concentration contained 456 cells per culture.  Had its plaque- 
forming capacity been as expected,  a mean of 24 plaques per cover slip would 
have been found, yet the actual mean was <  1. Unfortunately, there were three 
other experiments,  of identical design, which (as in Experiment  1 of Table V) 922  INHIBITION OF PERITONEAL CELL PLAQITES 
failed  to show this  dilution  effect.  Cell  dilution  methods  were  checked with 
~lCr-labeled  cells  and found to be valid.  No satisfactory explanation for this 
experimental variation is available. As in all experiments with retired breeders, 
the detailed pregnancy history, not avilable to us, may have been a significant 
variable. 
In order  to determine whether  the  decrease  in  plaque  formation resulting 
from decrease in cell concentration could be due to nonspecific factors, such as 
some nutritional  effect  akin  to  a  "feeder  layer"  function,  experiments  were 
performed in which PC were mixed with spleen cells in such a fashion that the 
PC concentration varied from 0 to 5 X  106/ml but the total cell concentration 
remained constant at 5  X  106/ml.  The results  (Table VI)  show that with  a 
falling PC  concentration, suboptimal plaque formation ensues.  It is unlikely 
that the reduction of plaque numbers by 60-80% of optimal levels could be due 
TABLE VI 
Effect of Concentration of Peritoneal Cells, at Constant Overall Cell Concentration, on the Forma- 
tion of Hemolytic Plaques. Young Male Mice, Open System 
Concentration of  Concentration of 
peritoneal cells  spleen cells 
PFC/10¢ peritoneal cells :t= SE 
Exp. 1  Exp. 2 
I06/mt  106/ml 
5  0  2210 4-  225  4770 4-  571 
2.5  2.5  1250 4-  204  4620 4-  1,100 
1.25  3.75  678  4-  115  2170 4-  121 
0.61  4.39  440  4-  146  2030 4-  530 
0  5  0  0 
solely to an inhibitor produced by spleen cells, as an addition of 5 X  106/ml of 
spleen cells  to a  preparation containing 5  X  106 PC/ml only causes a  fall  of 
20-30% in the expected plaque count (Tables II and III). 
Thus the fact that the activity of a population of cells from an immunized 
animal is independent of concentration can be interpreted as a demonstration 
that antibody formation, at this level, is an independent phenomenon for each 
individual cell. In contrast, the concentration dependence of the phenomenon 
of plaque formation by normal peritoneal cells,  shown here,  with a  new tech- 
nique of incubation and for young, as well as for old donors of cells, imply that 
cell to cell interaction is probably involved in some stages at least of the devel- 
opment  of  this  phenomenon.  Whether  this  interaction  requires  the  actual 
contact of cells or whether diffusible  factors are involved cannot be decided in 
the light of the experiments described here. It can only be mentioned that cell 
to cell  contact can take place in  the CMC.  This semisolid medium does not 
constitute an immobilizing environment for motile cells, as can be seen by time- 
lapse photography. This technique has allowed us to see that most cells from BUSSARD,  NOSSAL,  MAZIE,  AND  LEWIS  923 
the peritoneal cells suspensions  are moving (in the preparations). Lymphoid 
cells are endowed with peristaltic, nontranslational movements and wandering 
cells, with typical macrophage motility, are also to be seen in the preparations. 
Actual  fleeting contacts between  cells,  and  specially between  a  PFC  and  a 
macrophage, have been observed more than once. Whether these contacts have 
any significance is not known, but they are mentioned only in order to show that 
such contacts are possible. 
Effect oflnhibitors.--Different inhibitors have been studied, either by mixing 
the reagent in the whole incubation mixture, or by micromanipulation of active 
cells from a normal monolayer culture to one containing an inhibitor. 
Antimouse Immunoglobulin Sera.--Incubation of immune spleen cells (taken 
4  days after one intraperitoneal injection of 5  )<  108 SRBC)  and  of normal 
TABLE  VII 
Effect  of Antimouse  Immunoglobulin  Sera on Immune  Spleen  Cells or on Normal Peritoneal 
Cells. Young Male Mice, Closed System 
Percentage of activity related to controls 
Anti-IgM serum No. 1  Anti-IgM serum No. 2  Anti-IgG serum  Serum 
concentration 
Immune*  Peritoneal  Immune  Peritoneal  Immune~  Peritoneal 
spleen cells  cells  spleen cells  cells  spleen ceils  cells 
10  -¢  46§  5  21  0  1550  108 
10  -3  71  40  39  58  84  89 
10  -4  86  112  93  190  89  160 
* 4 day primary response. 
:~ Secondary reaction. 
§ Very small plaques. 
peritoneal cells have been performed, in CMC, with different concentrations of 
specific rabbit anti-mouse globulin antisera. Since normal rabbit serum has a 
slight inhibitory effect on plaque formation by peritoneal cells,  the effects of 
antisera are calculated as a percentage of the controls containing 1% normal 
rabbit serum. The plaque counts were done after 4 hr and 24 hr of incubation 
with the spleen cells and after 24, 48, and 72 hr of incubation with the peritoneal 
cells. The end points (24 hr for the spleen cells and 72 hr for the peritoneal cells) 
only  are  reported. 
The pooled results of five experiments are given on Table VII. It can be seen 
that the anti-IgM sera are more inhibitory on the peritoneal cells than on the 
spleen cells.  These results do not give a complete picture of the phenomenon 
since, after 4 hr of incubation the spleen cells were markedly more inhibited by 
the  anti-IgM  sera  than  after 24 hr.  It can be said  that  the plaque-forming 
activity of the spleen cells "overcame" the inhibitory effect of anti-IglV[  mole- 
cules after 4 hr in such a way that a large number of plaques will be seen at 24 924  INHIBITION  OF PERITONEAL  CELL  PLAQUES 
hr which are not present at 4 hr. This underlines the interest of long term incu- 
bation methods, such as the CMC one, for local hemolysis in gel studies. This 
presumably means  that  the  inhibition  of plaque formation is  due  more to a 
direct effect of the anti-IgM molecules on the local hemolysis of red cells than 
by an effect on the physiology of the antibody-producing cell.  Anyhow, "one- 
step experiments" such as the one reported here, do not allow one to distinguish, 
experimentally, between the two inhibitory mechanisms suggested. 
The anti-IgG serum manifests its usual amplification effect on immune spleen 
cells in a secondary immune response. This confirms the production of IgG by 
PFC/IOel 
6000  -- 
4000  -- 
2000  -  '•±2 
SE 
Cant  rol~without  Nor~mol  ,lO  -2  lO  -3  lO-~ 
serum  serum  anti IgM  serum 
FIG.  I.  Inhibition of plaque formation with various concentrations of rabbit anti-mouse 
IgM serum incorporated into the culture medium. Peritoneal cells in CMC open monolayer 
cultures, plaque counts read at 24 hr. 
these cells.  Peritoneal cells are essentially unaffected by the presence of anti- 
IgG antibody. The slight increase found with low concentration of anti-IgG is 
probably not significant. 
The results of a typical experiment using the open system are given in Fig. 1. 
Again,  there  is  a  profound  inhibitory  effect of the  anti-IgM  serum over the 
control with  normal rabbit serum  (96%  reduction).  As in  the closed system, 
anti-IgG sera had no greater inhibitory effect than did normal rabbit serum. 
The inhibitory effect of different normal rabbit sera varied greatly and presum- 
ably reflected the presence of some cytotoxic factor. 
Antimouse Immunoglobulin Sera Ejects as Judged by Transfer Technique.-- 
Micromanipulation of plaque-forming cells was performed as described in the BUSSARD,  NOSSAL,  MAZI]~,  AND  LEWIS  925 
previous article (1). Cells in the center of a plaque of hemolysis were taken and 
transferred into a new layer of CMC, normal or containing the proper reagent. 
Plaque formation by the transferred cells was observed repeatedly over 20 hr 
after the  transfer.  Effect of anti-IgM  or  anti-IgG sera was first  assayed  on 
immunized spleen cells (primary response). Transfers were made 1-3 hr after 
initial  culture  of the  cells  (Table  VIII). The  "plating  efficiency",  after one 
transfer,  was found  to be 87%  in  controls  (transfer from normal medium to 
normal medium). Anti-IgG serum at 1:100 final concentration in the recipient 
medium did not affect the plating efficiency. Anti-IgM serum (No. 2) at 1:500 
final concentration reduced the plating efficiency to 40 %  and anti-IgM serum 
at 1 : 100 final concentration brought it down to 25 %. This reduction in plaque- 
forming activity of immunized spleen cells (primary reaction)  transferred to a 
TABLE VIII 
Effect of Anti-Immunoglobulin  Antisera  on Appearance of Plaques After Micromanipulation 
Transfer of 4 Day Immunized  Spleen Cells 
No. of Plaques  Mean Diameter of  Inhibitor  No. Tested  Plaques 
%  /z 
Control:  26/30  87  198 
1  : 100 anti-IgG  15/15  100  166 
1  : 500 anti-IgM  6/15  40  53 
1 : 100 anti-IgM  5/20  25  129' 
* This included one very large plaque of 347 #.  The mean diameter of the other four 
plaques was 75 #. 
medium containing anti-IgM is quite comparable (Table VII) to the reduction 
found in plaque-forming capacity of immunized spleen cells incorporated in an 
anti-IgM-containing  medium. 
Micromanipulation  transfer  of  plaque-forming  peritoneal  cells  was  then 
undertaken  at  times varying from 3  to 24 hr  after initial  culture.  It can be 
seen, in Table IX, that the plating efficiency was 71%, in control transfers. At 
1:100 final concentration, a polyspecific rabbit antimouse globulin serum sup- 
pressed all activity in the transferred cells. Anti-IgM at 1% or 0.2 %  concentra- 
tion was also completely inhibitory. Anti-IgG serum, on the contrary, showed no 
inhibitory activity, the plating  efficiency of the  transferred population  being 
the same as that of the controls. A mixture of 0.5 %  anti-IgG and 0.5 %  anti- 
IgM is completely inhibitory. This may be considered as an indication that no 
double producers  (IgM and IgG produced by the  same cell)  could be found 
among the  100  cells transferred. 
Thus,  the results  of inhibition  by transfer experiments confirm completely 
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antisera. It leads us to conclude that peritoneal plaque-forming cells are IgM 
producers such as are spleen cells from a mouse 4  days after the first injection 
of sheep  erythrocytes. 
In order to see if inhibition of plaque formation by the transferred peritoneal 
cells was  achieved by an  irreversible damage of the cell, a  second transfer of 
these cells was  attempted.  PC  cells were first allowed to make plaques,  then 
transferred  to  a  monolayer  containing  anti-IgM,  and,  after  1  to  2  hr,  were 
retransferred  into  a  normal  monolayer.  The  results  of such  experiments  are 
reported in Table X. It is interesting to see that, although the cells have been 
TABLE IX 
Effect of Inhibitors on Plaque Formation after Micromanipulation Transfer of Peritoneal PFC 
No. of plaques 
Inhibitor in receptor gel  No. of cells  Plaques  Mean plaque  diameter  Transferred 
°70  /L 
Controls (No rabbit serum or 1% normal  60/85  71  173 
rabbit serum) 
1 : 100 rabbit anti-mouse globulin serum  0/20  0  -- 
1:100 or 1:500 rabbit anti-mouse IgG serum  37/50  74  167 
1 : 100 or 1 : 500 rabbit anti-mouse IgM serum  0/50  0  -- 
1:200  anti-IgM +  1:200 anti-IgG  0/100  0  -- 
TABLE X 
Reversibility of Inhibition  of Plaque Formation by Anti-IgM Sera 
No. of PFC tested on  No. forming plaques in  No. forming plaques on retransfer 
double transfer*  1:500 anti-IgM  to normal medium 
20  0  14 
* See text. 
submitted twice to the hazards of micromanipulation, they have survived in a 
high proportion to give a  final plating efficiency (14/20)  of the same order as 
that obtained after one transfer. 
It can then be concluded that the suppression of plaque formation by anti- 
IgM  antibody is not due to an irreversible cytotoxic effect on the hemolysin- 
producing cell. It is not possible to know yet if the inhibition effect is due to a 
blockade of the hemolytic process (as currently seems most likely), to a revers- 
ible switching off of the biosynthesis of antibody by the cell, or to a combination 
of  both  effects. 
E~ect of A ctinomycin D  on Plaque Formation.--Spleen  cells from immunized 
mice  have  been  shown  (9)  to  be  essentially insensitive to  actinomycin D  at 
concentrations from  1 to  10  #g/ml  in  terms  of their plaque-forming activity BUSSARD,  NOSSAL,  MAZIE,  AND  LEWIS  927 
with the closed technique. Peritoneal cells, on the other hand, have been shown 
(9) to be very sensitive to actinomycin D, with the closed system of incubation. 
The action of actinomycin D  was assayed with our new (open)  technique on 
PC from young mice or from retired breeders. 
Effects of actinomycin D  are different whether one considers peritoneal cells 
from young mice or from old breeders,  as can be seen from Table  XI,  which 
gives the results  of two representative experiments. At concentrations as low 
as  10  -2 #g/ml,  actinomycin suppresses 95 %  of the plaque-forming activity of 
PC from young male donors while, at such a concentration of inhibitor, 55 % of 
the cells from old breeders remain active. Even at a concentration of 10 #g/ml 
of actinomycin, 17 % of the cells from old mice are still active. 
Another interesting phenomenon in retired breeders is the fact that actino- 
mycin, at low concentrations, seems  to accelerate the  appearance of PFC in 
TABLE XI 
Effect of Actinomycin D on Plaque Formation by Peritoneal Cells from  Nonimmunized Mice 
Actinomycin 
#g/ml CMC 
Young Mice  Old breeders 
PFC/106  ±  SE  Control  PFC/l0 s -4- sE  Control 
%  % 
10  91  .4-  25  1.9  8,040 -4-  1,000  17 
1  64  -4-  15  1.4  7,370 -4-  1,120  15 
10  -1  23  4-  10  0.5  12,800 4-  1,500  27 
10  .2  246  .4- 37  5.2  26,600 .4-  2,500  55 
10  -3  3,060 .4-  620  65  33,400 .4-  1,270  70 
Controls  4,740  .4-  380  100  48,000 .4-  1,020  100 
the first hours of incubation. After this initial acceleration of plaque formation 
by the actinomycin, the speed of formation of new plaques decreases in com- 
parison with controls and, at the end, the final activity of the control group is 
higher than the activity of the actinomycin group even for the lowest concentra- 
tion of inhibitor (10  -3 #g/ml). This effect of low doses on the kinetics of plaque 
formation by peritoneal cells has been further investigated and will be discussed 
in the following article of this series. In one experiment in which 1 #g of actino- 
mycin had caused mild depression of final plaque numbers, we measured the 
diameters of 50 randomly chosen plaques from each sample. We found that the 
plaques  from  the  actinomycin group  were  much  smaller  (mean  diameters: 
controls,  292  /z;  actinomycin group,  120  #).  This  suggested  that  the  RNA 
molecules responsible for hemolysin production by the cell  had a  life  span of 
24  hr.  This  action of actinomycin D  on peritoneal  cells  from young donors 
observed with the new open technique, confirms our previous results obtained 
with  the closed technique.  In view of what has been found with immunized 
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ascribed to an overall cytotoxic effect (since the activity of these cells are not 
much affected by actinomycin D), except if one postulates a profound difference 
in susceptibility between peritoneal cells  from young mice and peritoneal cells 
from old mice or immunized spleen cells. 
In itself, the effect of actinomycin D  is interesting and may lead to the same 
interpretation for the behavior of peritoneal cells from young or old donors. If 
actinomycin D  acts on our peritoneal cells  at the same molecular level as it 
does generally, inhibition of DNA transcription in messenger RNA (m-RNA), 
we may interpret our results in considering that immune ceils and some of the 
peritoneal cells from old breeders contain  enough  stable m-RNA involved in 
production of specific IgM so that antibody production can take place in the 
absence of a  new formation of specific m-RNA. 
Effect  of  Colcemid  on  Plaque  Formalion.--The  addition  of  Colcemid  at 
various concentrations was found not to inhibit  the formation of plaques by 
TABLE XII 
Effect of Colcemide on Plaque Formation; Young Male Mice, Open System  (PFC/IO  G) 
Colcernide  (~g/ml) 
Control 
10  ~  10  -3  10-~ 
2733 4- 396*  2265 4-  310  1935 4-  328  2455 4-  348 
6126 4- 406  4575 4-  330  4510 4-  360  5410 :t=  310 
*2SE 
peritoneal cells from young mice (Table XlI). These results confirm our previous 
work (4) which showed that cell division was not required for the development 
of plaque-forming cells among the peritoneal cells incubated.  In view of the 
very rapid rise of PFC in our new technique (open system), it was hardly to be 
expected that cell division was involved in the development of the plaques of 
hemolysis. 
Effect of Puromycin on Plaque Formalion.--The effect of puromycin, a known 
inhibitor of protein synthesis, on plaque formation was assessed by incorporating 
the drug at a  concentration of 10 #g/ml in the culture monolayers. Progressive 
plaque appearance in cultures, with or without puromycin, was assessed using 
our three standard cell sources: spleen cells from in vivo immunized mice, and 
PC from unimmunized young male or retired breeder mice. The results at two 
of the time points monitored are given in Table XIII. The effects on immune 
spleen PFC are, at first sight, surprising. The plaque number was reduced only 
by a factor of 2, despite a concentration of drug which should have been highly 
inhibitory  to protein  synthesis.  The result is more readily appreciated when 
one bears in mind the great sensitivity of the present plaque detection method. 
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equal  to about 30 rain worth of production (10),  and thus secretion of stored 
product  alone  (presumably  not  immediately  affected  by  puromycin)  would 
release sufficient antibody to give a plaque in many instances. Accordingly, we 
preincubated  cells from immunized spleens for 1~  to 3  hr in a  liquid medium 
containing puromycin, and only then incorporated the cells into a puromycin- 
containing gel. Reductions of plaque counts down to 5 %  of control levels was 
readily achieved. 
The effect of puromycin on PC of young male mice (Table XIII) was much 
more marked than  that on immunized spleen  cells. At 3  hr,  three-quarters  of 
the  plaques  had  failed  to appear  in  the  presence  of the  inhibitor,  and,  most 
TABLE XIII 
Effect of Puromycin on Plaque Production by Spleen Cells  from Immunized Mice or by Peritoneal 
Cells  from Nonimmunized  Mice 
Nature  Type of mice  of cells 
Spleen cells 
Peritoneal 
cells 
Peritoneal 
cells 
Young male 
mice immu- 
nized 4 days 
previously 
Nonimmunized 
young male 
mice 
Nonimmunized 
retired  breeder 
mice 
Puromycin 
concen- 
tration 
0 
10 #g/ml 
0 
10 #g/ml 
0 
10 #g/ml 
3 hr culture 
I 
PFC/10  6-4- sE  IControl 
% 
4,810  -4- 510  -- 
2,640  ±  313  55 
290  ±  35  -- 
75  ±  14  26 
10,400  ±  769  -- 
8,440  ±  842  82 
22 hr culture 
PFC/10~ :t: SE  Control 
% 
4,730  ±  558  -- 
2,330  -4-  136  49 
4,210  4-  633  -- 
73  -4- 20  1.7 
49,300  -4- 5,130  -- 
9,330  ±  948  19 
significantly, no new plaques appeared over the next 19 hr, whereas in control 
cultures  the  plaque  count  rose  nearly  15-fold  over  this  interval.  As  in  the 
actinomycin D  experiments, the degree of inhibition achieved by puromycin was 
less for plaque formation by PC from retired breeders than for PC from young 
males.  However, with retired breeders  the plaque count also did not rise  sig- 
nificantly after 3 hr in the presence of puromycin. 
Thus, for the three types of cell populations considered, there is a compart- 
ment of PFC  (about 50% for immunized spleens,  20% for retired breeder PC 
and 2 % for young male PC) which is resistant to inhibition by puromycin and 
which expresses itself in 3 hr. The most likely explanation of this fraction is that 
they represent cells with stored antibody. Another possibility is that the rate of 
entry of puromycin into cells is, for some reason, low in the CMC system, thus 
leading  to apparently inefficient inhibitory  effects. 
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Inhibitory Sera.--A series of films were made of plaque formation by cells after 
micromanipulation  transfer.  The original plaque-forming PC  was  transferred 
into a  monolayer culture  containing  1:200 anti-IgM. After  1-4 hr time-lapse 
microcinematography,  the  cell  was  retransferred  into  a  monolayer  without 
inhibitor. After transfer into the IgM-containing monolayer, the cell continued 
to  live,  displaying  its  usual  "peristaltic",  nontranslational  movement.  No 
plaque appeared around the cell, although the films did reveal the lysis of 2-5 
SRBC  in the immediate vicinity of the cell.  On retransfer  to normal,  nonin- 
hibitory monolayers, the cell engendered plaque formation without detectable 
lag. The rate of plaque growth was, in general, quite standard, showing that the 
synthetic capacity of the  cell had not been affected by exposure  to the  anti- 
IgM serum.  However, in two of eight film sequences run in this fashion,  the 
PFC exhibited an apparent change in its movement pattern after exposure to 
anti-IgM. For 2-3 hr after retransfer to normal medium, it continued to behave 
normally, exhibiting peristaltic movement. Then, it suddenly displayed active 
translational  movement typical of that  of lymphocytes in nonviscous media. 
Long cytoplasmic processes were seen,  and red cells became attached  to their 
surface and were soon after lysed.  Secretion of antibody continued  while  the 
cell was moving so that in these two cases a  "snail-track"  of lysis outlined the 
path  of the cell,  and a  "satellite"  plaque developed around the area,  100-200 
#  away from its  original  location,  where  the  cell finally  settled  down.  Some 
features  of this process are seen in Fig.  2. We interpret  this to be an irritant 
effect of anti-IgM  on the lymphocyte cell membrane,  but have not yet per- 
formed  an  extensive  series  of control  experiments  involving  other  inhibitory 
antisera. 
DISCUSSION 
The chief findings of this paper can be summarized as follows: 
(a)  The  appearance  of hemolytic plaques  in culture monolayers containing 
FIG. 2. Behavior of a peritoneal cell from a young male mouse taken from the center of a 
plaque  20 hr after  the beginning of CMC  open microculture,  and transferred  serially by 
micromanipulafion into two CMC monolayers, the first containing  1:200 rabbit anti-mouse 
IgM serum,  and  the second being a  normal  SRBC-CMC-complement  monolayer.  Frames 
from time-lapse microcinematographic film. The arrow identifies the PFC. (a) 1 hr after trans- 
fer to monolayer containing anfi-IgM.  No plaque has formed. (b) 15 min after retransfer  to 
normal monolayer. A small plaque is present, the cell is round and at the center of the plaque. 
(c) After 2 hr of culture in the normal gel. The cell has started  to show active translational 
movement. This is unusual,  and may or may not have been due to the irritating  effects of 
anti-IgM on the cell membrane. SRBC are adhering to the PFC; they will shortly be lysed. 
(d)  Mter 3~  hr culture  in the normal gel. The PFC has moved right  out of the original 
plaque  and is beginning to cause lysis in another  area. In 1-2 hr,  a "satellite"  plaque will 
appear  here. More  SRBC  are attached  to the surface of the PFC; they will also be lysed 
shortly.  X  160. 932  INIt'IBITION  OF  PERITONEAL  CELL  PLAQUES 
PC can be specifically and reversibly inhibited by rabbit anti-mouse IgM serum. 
This strengthens the arguments already advanced for this response being due to 
antibody formation. 
(b) The appearance of plaques is dependent on peritoneal ceils in an optimal 
concentration. It cannot be mimicked by lymphoid cells from other sources; 
whatever mixtures have been tried are ineffective. The data, though incomplete, 
suggest that optimal plaque formation depends on some cell to cell interactions 
between PC which is neither a macrophage-lymphocyte interaction nor a non- 
specific feeder-layer effect. 
(c) The induction of antibody, formation in PC is entirely independent of cell 
division in vitro and only variably dependent on messenger RNA  synthesis. 
Actinomycin D  is a potent (98 %) inhibitor of plaque appearance when young 
male mice are used, and is ineffective, as expected, in the case of preimmunized 
spleen cells. With PC from retired breeder mice, a substantial compartment of 
cells exists which can form plaques even in the presence of high concentrations 
of actinomycin D, suggesting that such ceils contained the necessary messenger 
RNA at the time of killing of the animal. 
Taken as a whole, the inhibitor experiments reinforce the view expressed in 
the first paper that  we are dealing here with  the induction of some kind of 
a typical immunological recall phenomenon. It now seems proven beyond reason- 
able doubt that the PC are forming hemolytic, IgM antibody against SRBC. 
The puromycin results suggest that most PC must synthesize this IgM de novo 
in cultures, an argument strongly against the notion of cytophilic antibody as 
the basis of this phenomenon. The actinomycin D  experiments imply that new 
RNA synthesis is involved, presumably because antigen subserves some induc- 
tive or derepressive function. However, the speed of the induction and the total 
failure of mitotic poisons to inhibit it place the phenomenon in striking contrast 
to the usual systems of the induction of primary immune responses in vitro. A 
speculative explanation may be that the PC populations contain a  novel kind 
of memory cell,  stimulated in vivo by some cross-reacting antigen of food or 
autologous origin, which has the characteristic of being fired off quickly and 
without cell division in the CMC cultures. In that case, the higher reactivity, 
greater  actinomycin D  and puromycin resistance,  and more rapid  induction 
kinetics  of the  retired breeder mice could all be explained by postulating  a 
greater degree of this hypothetical prestimnlation. 
As regards the cell to cell interaction work, clearly much remains to be done. 
For example, no experiments on neonatally thymectomized or irradiated and 
restored mice have yet been performed. In considering the immune response of 
the intact mouse to SRBC,  it appears that a  collaboration between thymus- 
derived and bone marrow-derived lymphocytes is required for optimal activity 
(3, 6), but this needs to be investigated as regards this PC inductive phenom- 
enon.  We  hope  to  clarify this  issue  and  also  to  embark  on more definitive BUSSARD,  NOSSAL,  M_AZII~, AND  LEWIS  933 
biophysical separation techniques. Despite these limitations in our knowledge, 
we consider this dependence on cell concentration one of the strongest argu- 
ments against the view that our system is measuring a background phenomenon 
of little inherent interest. 
The actual  contact between a  macrophage and a  PFC  seen from time to 
time in cinematographic observations proves that cell to cell contact is possible 
in our semisolid system. It does not, by any means, prove that this is the ordi- 
nary pathway for the immune response triggered in vitro, but, simply, that the 
physical conditions  existing in  the  semisolid environment do not forbid cell 
agitation and contact between cells. 
Finally, it is our impression that the system of ultrathin layer culture may be 
of great use for the study of different steps of the immune response at the cellular 
level. It allows fine observation of cell physiology, as well as actual manipula- 
tion of the active cell. By contrast with the Jerne or Cunningham techniques, 
which are believed to measure only those cells actually forming antibody in vivo 
at the moment of killing  of the  animal,  the  CMC  system  allows functional 
survival of cells for at least 24 hr, together with continuous monitoring of anti- 
body-forming capacity. During this period it is evident that regulatory changes 
of a profound nature take place in the cell population. Whether these represent 
the beginning of a  true immune induction in the usual sense of the word, or 
some derepression of cells already precommitted to the formation of antibodies 
which can lyse SRBC is not yet clear. In either case, the fact that lymphoid cells 
from normal mice can be induced to form up to 100,000 PFC/106 cells plated 
within 24 hr and without cell division, must henceforth be taken into account 
by all students of the immune response using this species and this antigen. 
S~M~ARY 
Peritoneal cells (PC) from normal, unimmunized mice were placed in ultra- 
thin monolayer cultures containing carboxymethylcellulose (CMC), sheep red 
blood ceils (SRBC), and complement, and tested for the appearance of plaques 
of lysis. The behavior of PC from young male mice and from female mice that 
had given birth to several litters (retired breeder mice) was studied. 
It was found that cells from spleen, mesenteric lymph node, thymus, bone 
marrow, thoracic duct lymph, or Peyer's patches could not form plaques in the 
CMC microcultures. Also, various combinations of these cells did not lead to 
plaque formation. When cells from any of these sources were mixed with PC, 
there was either no effect or an actual inhibition of plaque formation, the plaque 
counts being lower than would have been expected from the number of PC 
present in the mixture. 
Optimal plaque formation by peritoneal cells was found to be dependent on 
an optimal cell concentration, this optimum being around 5 ;< 106/ml for young 
male mice and 0.5 >( 106/ml for retired breeders. Inhibition of plaque formation 934  INI-IIBITION OF  PERITONEAL  CELL  PLAQUES 
was found with either supra- or suboptimal cell concentrations. The inhibition 
by excess cell concentration may have been a simple nutritional  or nonspecific 
overcrowding effect, as it could also be induced by an addition of an excess of 
spleen or lymph node cells.  The failure of more dilute PC preparations to give 
adequate numbers of plaques appeared to be more specific, as plaque numbers 
could not be restored to normal by addition of spleen cells. The suggestion was 
that some cell to cell interaction between PC was involved. This dependence 
on cell concentration was not seen with immunized spleen PFC. 
Plaque appearance could be specifically and reversibly suppressed by placing 
PC in a medium containing rabbit anti-mouse IgM serum. Anti-IgG serum had 
no such effect. These experiments strengthened  our view, expressed in the ac- 
companying paper,  that plaque formation was due to the formation of IgM, 
hemolytic antibody to SRBC by the PC. 
Metabolic  inhibitors  were  incorporated  into  monolayer  cultures  and  had 
different effects with the different types of PFC used. In the case of spleen cells 
from mice actively immunized against SRBC 4 days before killing, actinomycin 
D  had no effect on plaque counts and puromycin reduced plaque numbers by 
a factor of 2. In the case of PC from young male mice, actinomycin D  in con- 
centrations  above 0.01  ttg/ml  caused  reductions  down  to  <  2%  of  control 
values in plaque counts,  and puromycin (10 #g/ml) had a  similar effect. The 
PC  from retired breeder mice occupied an intermediate position between  the 
two cases just discussed. A compartment of cells, equal to about one-fifth of the 
total  normal  PFC  compartment,  was  identified  as  resistant  to high  concen- 
trations of either actinomycin D  or puromycin, being similar in these respects 
to PFC from spleens of intentionally preimmunized mice. The mitotic poison, 
Colcemid, did not affect plaque counts in any situation tested. 
The theoretical implications of these results are briefly discussed. 
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